IOL CHEMICALS & PHARM. | TYCHE INDUSTRIES | IOL CHEMICALS & PHARM./ TYCHE INDUSTRIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 15.5 | 84.7% | View Chart |
P/BV | x | 1.5 | 1.9 | 79.0% | View Chart |
Dividend Yield | % | 1.0 | 0.9 | 112.2% |
IOL CHEMICALS & PHARM. TYCHE INDUSTRIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
TYCHE INDUSTRIES Mar-23 |
IOL CHEMICALS & PHARM./ TYCHE INDUSTRIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 163 | 329.7% | |
Low | Rs | 272 | 105 | 259.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 73.5 | 513.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 13.8 | 171.4% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 15.6 | 202.9% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.00 | 200.0% | |
Avg Dividend yield | % | 1.0 | 1.5 | 66.2% | |
Book value per share (Unadj.) | Rs | 256.8 | 113.9 | 225.5% | |
Shares outstanding (eoy) | m | 58.71 | 10.25 | 572.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.8 | 58.8% | |
Avg P/E ratio | x | 17.1 | 9.7 | 176.2% | |
P/CF ratio (eoy) | x | 12.8 | 8.6 | 148.9% | |
Price / Book Value ratio | x | 1.6 | 1.2 | 134.0% | |
Dividend payout | % | 16.9 | 14.5 | 116.7% | |
Avg Mkt Cap | Rs m | 23,743 | 1,372 | 1,730.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 70 | 2,417.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 754 | 2,941.0% | |
Other income | Rs m | 256 | 48 | 530.4% | |
Total revenues | Rs m | 22,427 | 802 | 2,796.0% | |
Gross profit | Rs m | 2,257 | 160 | 1,407.7% | |
Depreciation | Rs m | 462 | 18 | 2,603.5% | |
Interest | Rs m | 165 | 0 | 1,647,000.0% | |
Profit before tax | Rs m | 1,887 | 191 | 988.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 49 | 1,007.7% | |
Profit after tax | Rs m | 1,391 | 142 | 981.8% | |
Gross profit margin | % | 10.2 | 21.3 | 47.9% | |
Effective tax rate | % | 26.2 | 25.7 | 101.9% | |
Net profit margin | % | 6.3 | 18.8 | 33.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,219 | 792.9% | |
Current liabilities | Rs m | 5,025 | 210 | 2,395.9% | |
Net working cap to sales | % | 20.9 | 133.9 | 15.6% | |
Current ratio | x | 1.9 | 5.8 | 33.1% | |
Inventory Days | Days | 43 | 13 | 344.3% | |
Debtors Days | Days | 8 | 1,069 | 0.8% | |
Net fixed assets | Rs m | 11,017 | 192 | 5,736.1% | |
Share capital | Rs m | 587 | 102 | 573.1% | |
"Free" reserves | Rs m | 14,490 | 1,065 | 1,360.5% | |
Net worth | Rs m | 15,077 | 1,168 | 1,291.4% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 1,411 | 1,465.7% | |
Interest coverage | x | 12.5 | 19,085.0 | 0.1% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.5 | 200.7% | |
Return on assets | % | 7.5 | 10.0 | 74.9% | |
Return on equity | % | 9.2 | 12.1 | 76.0% | |
Return on capital | % | 13.6 | 16.3 | 83.2% | |
Exports to sales | % | 26.7 | 57.9 | 46.2% | |
Imports to sales | % | 0 | 19.9 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 437 | 1,358.2% | |
Imports (cif) | Rs m | NA | 150 | 0.0% | |
Fx inflow | Rs m | 5,930 | 437 | 1,358.2% | |
Fx outflow | Rs m | 6,052 | 161 | 3,749.8% | |
Net fx | Rs m | -122 | 275 | -44.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 68 | 1,792.3% | |
From Investments | Rs m | -1,200 | 19 | -6,179.2% | |
From Financial Activity | Rs m | -41 | -15 | 267.6% | |
Net Cashflow | Rs m | -18 | 72 | -25.5% |
Indian Promoters | % | 48.2 | 62.0 | 77.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 38.0 | 136.2% | |
Shareholders | 130,003 | 8,221 | 1,581.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | TYCHE INDUSTRIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.10% | -0.32% | -0.44% |
1-Month | -4.43% | 20.23% | 2.15% |
1-Year | -4.01% | 32.68% | 49.82% |
3-Year CAGR | -11.98% | 7.66% | 14.21% |
5-Year CAGR | 15.37% | 26.01% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the TYCHE INDUSTRIES share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of TYCHE INDUSTRIES the stake stands at 62.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of TYCHE INDUSTRIES.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
TYCHE INDUSTRIES paid Rs 2.0, and its dividend payout ratio stood at 14.5%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of TYCHE INDUSTRIES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.